C. P. Mccarthy, M. Vaduganathan, K. J. Mccarthy, J. L. Januzzi, D. L. Bhatt et al., Left Ventricular Thrombus After Acute Myocardial Infarction: Screening, Prevention, and Treatment, JAMA Cardiology, vol.3, p.642, 2018.

C. P. Mccarthy, S. Murphy, R. V. Venkateswaran, A. Singh, L. L. Chang et al., Left Ventricular Thrombus, Journal of the American College of Cardiology, vol.73, pp.2007-2016, 2019.

F. Zannad, W. G. Stough, V. Regnault, M. Gheorghiade, E. Deliargyris et al., Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges, International Journal of Cardiology, vol.167, pp.1772-82, 2013.

F. Zannad, S. D. Anker, W. M. Byra, J. Cleland, M. Fu et al., Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease, New England Journal of Medicine, vol.379, pp.1332-1374, 2018.

B. M. Massie, J. F. Collins, S. E. Ammon, P. W. Armstrong, J. Cleland et al., Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure: The Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) Trial, Circulation, vol.119, pp.1616-1640, 2009.

D. V. Cokkinos, G. C. Haralabopoulos, J. B. Kostis, and P. K. Toutouzas, for the HELAS investigators. Efficacy of antithrombotic therapy in chronic heart failure: The HELAS study, European Journal of Heart Failure, vol.8, pp.428-460, 2006.

J. Cleland, I. Findlay, S. Jafri, G. Sutton, R. Falk et al., The Warfarin/Aspirin study in heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure, American Heart Journal, vol.148, pp.157-64, 2004.

S. Homma, J. Thompson, P. M. Pullicino, B. Levin, R. S. Freudenberger et al., Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm, New England Journal of Medicine, vol.366, pp.1859-69, 2012.

P. Ponikowski, A. A. Voors, S. D. Anker, H. Bueno, J. Cleland et al., ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC, European Heart Journal, vol.37, pp.2129-200, 2016.

J. M. Lee, J. J. Park, H. W. Jung, Y. Cho, I. Oh et al., Left Ventricular Thrombus and Subsequent Thromboembolism, Comparison of Anticoagulation, Surgical Removal, and Antiplatelet Agents, Journal of Atherosclerosis and Thrombosis, vol.20, pp.73-93, 2013.

I. Hopper, M. Skiba, and H. Krum, Updated meta-analysis on antithrombotic therapy in patients with heart failure and sinus rhythm, European Journal of Heart Failure, vol.15, pp.69-78, 2013.

M. R. Mehra, M. Vaduganathan, M. Fu, J. P. Ferreira, S. D. Anker et al., A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial, European Heart Journal, 2019.

J. S. Gottdiener, J. A. Gay, L. Vanvoorhees, R. Dibianco, and R. D. Fletcher, Frequency and embolic potential of left ventricular thrombus in dilated cardiomyopathy: Assessment by 2-dimensional echocardiography, The American Journal of Cardiology, vol.52, pp.1281-1286, 1983.

M. Ciaccheri, G. Castelli, F. Cecchi, M. Nannini, G. Santoro et al., Lack of correlation between intracavitary thrombosis detected by cross sectional echocardiography and systemic emboli in patients with dilated cardiomyopathy, Heart, vol.62, pp.26-35, 1989.

S. D. Katz, Left ventricular thrombus and the incidence of thromboembolism in patients with congestive heart failure: can clinical factors identify patients at increased risk?, Journal of Cardiovascular Risk, vol.2, p.6, 1995.

G. Cioffi, M. Pozzoli, G. Forni, M. Franchini, C. Opasich et al., Systemic thromboembolism in chronic heart failure: A prospective study in 406 patients, European Heart Journal, vol.17, pp.1381-1390, 1996.

K. Nakasuka, S. Ito, T. Noda, T. Hasuo, S. Sekimoto et al., Resolution of Left Ventricular Thrombus Secondary to Tachycardia-Induced Heart Failure with Rivaroxaban, Case Reports in Medicine, vol.2014, pp.1-5, 2014.

S. Kolekar, C. Munjewar, and S. Sharma, Dabigatran for left ventricular thrombus, Indian Heart Journal, vol.67, pp.495-501, 2015.